Paraoxonase 2 prevents the development of heart failure.

Autor: Li W; Department of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, WV, United States., Kennedy D; Department of Medicine, University of Toledo, OH, United States., Shao Z; Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, OH, United States., Wang X; Department of Medicine, Stanford University School of Medicine, CA, United States., Kamdar AK; Department of Medicine, University of Minnesota, MN, United States., Weber M; Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, OH, United States., Mislick K; Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, OH, United States., Kiefer K; Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, OH, United States., Morales R; Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, OH, United States., Agatisa-Boyle B; Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, OH, United States., Shih DM; Department of Medicine, Division of Cardiology, University of California at Los Angeles, Los Angeles, CA, United States., Reddy ST; Department of Medicine, Division of Cardiology, University of California at Los Angeles, Los Angeles, CA, United States., Moravec CS; Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, OH, United States., Tang WHW; Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, OH, United States; Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, OH, United States; Center for Clinical Genomics, Cleveland Clinic, OH, United States. Electronic address: tangw@ccf.org.

Publikováno v: Free radical biology & medicine [Free Radic Biol Med] 2018 Jun; Vol. 121, pp. 117-126. Date of Electronic Publication: 2018 May 02.